NS Medical Devices is using cookies
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Press
Release
A case study of the Amber was made available on-site to the conference attendees and was well received. Innovative initiatives such as integrating NFC within labels were also featured on the device, allowing users to link to the device specifications online by simply placing a smart phone on top of the label. This can of course be configured to link to other tools such as IFUs and videos to further assist users with correct usage.
Interest continued to be apparent for the Molly™ auto injector, which appealed to many biopharmaceutical customers due to its compact size and business model. A corresponding case study was also available on the Molly at the conference, highlighting the device’s original design concepts as well as how the various challenges were overcame during development. A third case study on the PPI™ Injector wrapped up the set of three SHL case studies that were officially launched at the conference. All three case studies are now available for download in the case studies area.
Commenting on the success of this year’s conference, VP of global marketing Steven Kaufman expresses, “Conferences like the PDA help us connect with various customers and partners and give us the opportunity to speak to them face to face. Having a large booth and several SHL staff with broad experiences on-site allowed us to not only demonstrate our latest technologies, but also to gain insight into the needs of biopharma customers at a high level. I commend the PDA for their efforts in making the talks interesting and technical, and of course their success in attracting a diverse number of companies that clearly need auto injector and pen injector support.”
Furthermore, SHL was featured in the latest edition of the On Drug Delivery and Drug Development and Delivery magazines, both of which were distributed at the PDA.
About SHL
SHL is the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices such as auto injectors and pen injectors. We have over 2,600 staff globally, with our primary design centres located in the US and Sweden and manufacturing centres located in Asia. SHL supplies auto injectors, pen injectors and inhaler systems to global pharmaceutical and biotech companies. Significant investment in R&D has enhanced our broad pipeline of ‘next generation’ drug delivery systems. These innovative devices include a range of disposable and reusable injectors with fixed or variable dosing, enhanced precision and the ability to accommodate high viscosities.
Our organisation consists of several distinct group companies:
SHL Medical
Designs, develops and manufactures advanced drug delivery devices for leading pharmaceutical and biotech companies
SHL Healthcare
Develops and manufactures equipment solutions for home, hospital and long term care use
SHL Technologies
Provides contract manufacturing and engineering services for the production of complex medtech and industrial products
SHL Pharma
Provides final assembly, labelling and packaging services of drug delivery devices to the pharmaceutical and biotechnology industries
For additional information visit www.shl-group.com or contact us at info@shl-group.com
SHL Media Contact
Steven R. Kaufman
VP of Marketing
+886 32170303